Search

Marsha M. Tsay

Examiner (ID: 10087, Phone: (571)272-2938 , Office: P/1656 )

Most Active Art Unit
1656
Art Unit(s)
1656, 1653
Total Applications
1119
Issued Applications
471
Pending Applications
134
Abandoned Applications
540

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20264375 [patent_doc_number] => 12435353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-07 [patent_title] => Biomarker assay for use in monitoring autism [patent_app_type] => utility [patent_app_number] => 18/470985 [patent_app_country] => US [patent_app_date] => 2023-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470985 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/470985
Biomarker assay for use in monitoring autism Sep 19, 2023 Issued
Array ( [id] => 20068887 [patent_doc_number] => 20250207109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => ENGINEERED SPLIT DHFR-BASED METHODS AND SYSTEMS FOR SELECTING CELLS THAT HAVE STABLY ACQUIRED A HETEROLOGOUS POLYNUCLEOTIDE [patent_app_type] => utility [patent_app_number] => 18/709446 [patent_app_country] => US [patent_app_date] => 2023-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11503 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18709446 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/709446
ENGINEERED SPLIT DHFR-BASED METHODS AND SYSTEMS FOR SELECTING CELLS THAT HAVE STABLY ACQUIRED A HETEROLOGOUS POLYNUCLEOTIDE Sep 19, 2023 Pending
Array ( [id] => 19067199 [patent_doc_number] => 20240101625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE [patent_app_type] => utility [patent_app_number] => 18/461658 [patent_app_country] => US [patent_app_date] => 2023-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16150 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18461658 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/461658
EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE Sep 5, 2023 Abandoned
Array ( [id] => 19390723 [patent_doc_number] => 20240280593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS [patent_app_type] => utility [patent_app_number] => 18/231880 [patent_app_country] => US [patent_app_date] => 2023-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18231880 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/231880
METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS Aug 8, 2023 Abandoned
Array ( [id] => 18754357 [patent_doc_number] => 20230357762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE [patent_app_type] => utility [patent_app_number] => 18/351241 [patent_app_country] => US [patent_app_date] => 2023-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5131 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351241 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/351241
EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE Jul 11, 2023 Pending
Array ( [id] => 18972231 [patent_doc_number] => 20240052323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => MODIFIED TRANSGLUTAMINASE [patent_app_type] => utility [patent_app_number] => 18/212427 [patent_app_country] => US [patent_app_date] => 2023-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27500 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18212427 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/212427
MODIFIED TRANSGLUTAMINASE Jun 20, 2023 Pending
Array ( [id] => 18726234 [patent_doc_number] => 20230340501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => COORDINATED COEXPRESSION OF THROMBIN [patent_app_type] => utility [patent_app_number] => 18/310317 [patent_app_country] => US [patent_app_date] => 2023-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28116 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18310317 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/310317
COORDINATED COEXPRESSION OF THROMBIN Apr 30, 2023 Abandoned
Array ( [id] => 18649763 [patent_doc_number] => 20230295584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE [patent_app_type] => utility [patent_app_number] => 18/131968 [patent_app_country] => US [patent_app_date] => 2023-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4101 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131968 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/131968
BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE Apr 6, 2023 Pending
Array ( [id] => 18649763 [patent_doc_number] => 20230295584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE [patent_app_type] => utility [patent_app_number] => 18/131968 [patent_app_country] => US [patent_app_date] => 2023-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4101 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131968 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/131968
BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE Apr 6, 2023 Pending
Array ( [id] => 18860272 [patent_doc_number] => 20230414706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES [patent_app_type] => utility [patent_app_number] => 18/296454 [patent_app_country] => US [patent_app_date] => 2023-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296454 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/296454
COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES Apr 5, 2023 Pending
Array ( [id] => 18860272 [patent_doc_number] => 20230414706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES [patent_app_type] => utility [patent_app_number] => 18/296454 [patent_app_country] => US [patent_app_date] => 2023-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296454 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/296454
COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES Apr 5, 2023 Pending
Array ( [id] => 18647986 [patent_doc_number] => 20230293769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => ENGINEERED TISSUES HAVING STRUCTURAL COMPONENTS EMBEDDED THEREIN, AND METHODS OF MAKING AND USING [patent_app_type] => utility [patent_app_number] => 18/123157 [patent_app_country] => US [patent_app_date] => 2023-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4617 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18123157 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/123157
ENGINEERED TISSUES HAVING STRUCTURAL COMPONENTS EMBEDDED THEREIN, AND METHODS OF MAKING AND USING Mar 16, 2023 Abandoned
Array ( [id] => 18552403 [patent_doc_number] => 20230250412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => Compositions and Methods for Modulating Factor IX Function [patent_app_type] => utility [patent_app_number] => 18/176546 [patent_app_country] => US [patent_app_date] => 2023-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7873 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176546 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/176546
Compositions and Methods for Modulating Factor IX Function Feb 28, 2023 Pending
Array ( [id] => 18955142 [patent_doc_number] => 20240043469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => MANUFACTURE OF ENDOTOXIN-FREE HEMOGLOBIN-BASED DRUG SUBSTANCE AND METHOD FOR ENDOTOXIN-FREE PROTEIN PURIFICATION [patent_app_type] => utility [patent_app_number] => 18/115724 [patent_app_country] => US [patent_app_date] => 2023-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16008 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18115724 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/115724
MANUFACTURE OF ENDOTOXIN-FREE HEMOGLOBIN-BASED DRUG SUBSTANCE AND METHOD FOR ENDOTOXIN-FREE PROTEIN PURIFICATION Feb 27, 2023 Abandoned
Array ( [id] => 19404045 [patent_doc_number] => 20240287556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => USING BIOSOURCED RAWS FROM WASTE STREAMS TO MAKE SOURCE MATERIALS FOR OILFIELD CHEMICAL MANUFACTURE [patent_app_type] => utility [patent_app_number] => 18/115585 [patent_app_country] => US [patent_app_date] => 2023-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6586 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18115585 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/115585
USING BIOSOURCED RAWS FROM WASTE STREAMS TO MAKE SOURCE MATERIALS FOR OILFIELD CHEMICAL MANUFACTURE Feb 27, 2023 Abandoned
Array ( [id] => 18692955 [patent_doc_number] => 20230323314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => INCREASING PRODUCTIVITY OF E. COLI HOST CELLS THAT FUNCTIONALLY EXPRESS P450 ENZYMES [patent_app_type] => utility [patent_app_number] => 18/161938 [patent_app_country] => US [patent_app_date] => 2023-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11099 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18161938 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/161938
INCREASING PRODUCTIVITY OF E. COLI HOST CELLS THAT FUNCTIONALLY EXPRESS P450 ENZYMES Jan 30, 2023 Pending
Array ( [id] => 18390281 [patent_doc_number] => 20230158499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood [patent_app_type] => utility [patent_app_number] => 18/159283 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13233 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159283 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/159283
Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood Jan 24, 2023 Abandoned
Array ( [id] => 18404904 [patent_doc_number] => 20230166255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood [patent_app_type] => utility [patent_app_number] => 18/159281 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13257 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159281 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/159281
Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood Jan 24, 2023 Pending
Array ( [id] => 18390280 [patent_doc_number] => 20230158498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood [patent_app_type] => utility [patent_app_number] => 18/159276 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159276 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/159276
Methods And Devices For Detection Of Anticoagulants In Plasma And Whole Blood Jan 24, 2023 Abandoned
Array ( [id] => 18709574 [patent_doc_number] => 20230332194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING ADIPATE, 6-AMINOCAPROATE, HEXAMETHYLENEDIAMINE OR CAPROLACTAM RELATED THERETO [patent_app_type] => utility [patent_app_number] => 18/158680 [patent_app_country] => US [patent_app_date] => 2023-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84074 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18158680 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/158680
MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING ADIPATE, 6-AMINOCAPROATE, HEXAMETHYLENEDIAMINE OR CAPROLACTAM RELATED THERETO Jan 23, 2023 Abandoned
Menu